Head-to-head · Cost-Efficiency Index
Wisp vs MEDGm
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Wisp
Cost-first shoppers who want branded injectables plus a sublingual semaglutide alternative.
Visit WispMEDGm
Readers who want the dispensing pharmacies and the prescribing practices named, and who will price the second month rather than the first.
Visit MEDGmThe verdict
Wisp takes it, leading the Cost-Efficiency Index 63 to 60. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month. MEDGm still earns a C — Readers who want the dispensing pharmacies and the prescribing practices named, and who will price the second month rather than the first.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Wisp.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Wisp | MEDGm |
|---|---|---|
| Cost-Efficiency Index | 63/100 | 60/100 |
| Semaglutide / mo | $225/mo (compounded oral) | $299/mo month-to-month (the advertised $179 is the first month only, after an automatically applied coupon) |
| Tirzepatide / mo | Not disclosed | $399/mo month-to-month (the advertised $279 is the first month only) |
| Semaglutide / yr (modeled) | $2,700 | $3,588 |
| Tirzepatide / yr (modeled) | — | $4,788 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #192 | #193 |
Wisp
63/100Where the value is
- Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
- LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
- Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary
The tradeoffs
- The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
- The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
MEDGm
60/100Where the value is
- Names all four pharmacy partners in its terms, with street addresses, phone numbers and websites, and says which compounding classes they operate under
- Names seven prescribing professional corporations on its consent page rather than referring to an unnamed medical group
- Publishes the full ladder for three GLP-1 routes — injection, oral tablet and tirzepatide — at one, three, six and twelve months
The tradeoffs
- "Starting at $179" is a first-month rate produced by an automatically applied coupon; the standing month-to-month price is $299, and the same shape applies to the oral tablet and to tirzepatide
- The treatments FAQ says "your price never increases" on a plan whose price increases by $120 at the first renewal
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.